Ascletis phase I COVID trial progressing
Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation…
January 17, 2023 - 3 minutes
Ascletis Pharma Inc
Ascletis announces positive COVID-19 trial results
Ascletis Pharma Inc. has announced positive topline results from its phase I multiple ascending dose…
December 13, 2022 - 3 minutes
FDA gives IND approval for Ascletis Covid drug
Ascletis Pharma Inc. has revealed that the U.S. Food and Drug Administration (FDA) has approved…
November 24, 2022 - 2 minutes
Ascletis announces IND approval for treatment of advanced solid tumors
Ascletis Pharma has announced the approval of the investigational new drug (IND) application by China…
November 17, 2022 - 2 minutes
Ascletis’ monkeypox tablet receives IND approval from the FDA
A drug to treat monkeypox from Ascletis Pharma has had its investigational new drug (IND)…
November 16, 2022 - 3 minutes
Ascletis is first Chinese biotech company to get IND approvals for oral RdRp inhibitor
An investigational new drug (IND) application for a COVID-19 treatment has been approved by the…
August 22, 2022 - 2 minutes
Ascletis announces FDA clearance of oral drug to conduct study in mild to moderate COVID-19 patients
A randomized, placebo-controlled study in mild to moderate COVID-19 patients has been approved by the…
August 3, 2022 - 2 minutes
